[Treatment of malignant nephroangiosclerosis with diazoxide].
D003981:Diazoxide / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000188:drug therapy*; D007275:Injections, Intravenous; D007671:Kidney Concentrating Ability; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D008750:Methyldopa / Q000627:therapeutic use; D009400:Nephrosclerosis / Q000188:drug therapy*
D006830:Hydralazine; D008750:Methyldopa; D003981:Diazoxide
Le traitement des néphroangioscléroses malignes par le diazoxide.